Literature DB >> 19597857

Enhanced expression of engineered ACA-less beta-1, 6-N-acetylglucosaminidase (dispersin B) in Escherichia coli.

Nandadeva Yakandawala1, Purushottam V Gawande, Karen LoVetri, Tony Romeo, Jeffrey B Kaplan, Srinivasa Madhyastha.   

Abstract

beta-1,6-N-Acetylglucosaminidase (dispersin B), which cleaves poly-ss-(1,6)-linked N-acetylglucosamine, is encoded by dspB of Aggregatibacter actinomycetemcomitans. To enhance the production of dispersin B, we engineered dspB to transcribe mRNAs devoid of the trinucleotide ACA. Transcription and translation levels of ACA-less and wild-type dspB expressed in Escherichia coli (E. coli) under T5 and T7 promoters were analyzed by real-time RT-PCR and protein quantification, respectively. The ACA-less dspB mRNA level was significantly higher (P < 0.01) and produced 77.6 and 34.9% more dispersin B than wild-type dspB expressed under T7 and T5 promoters, respectively. Dispersin B expression under T7 promoter caused a 98-99.5% drop in the glyceraldehyde-3-phosphate dehydrogenase (gapA) mRNA level, which was not observed with T5 promoter. Fusion of green fluorescent protein (GFP) with dispersin B allowed rapid quantification of dispersin B production by measuring fluorescence intensity in culture broth. Although the cultures containing 0.1% glucose showed sustained increase in dispersin B-GFP production until 12 h, no significant increase in dispersin B activity was observed beyond 4 and 6 h after induction when expressed under T7 and T5 promoters, respectively. This study demonstrates the effectiveness of ACA-less mRNA and the advantage of GFP tagging for enhanced dispersin B production and quantification, which could be adapted for improving the production of other commercially important proteins in E. coli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597857     DOI: 10.1007/s10295-009-0613-0

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  21 in total

1.  Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity.

Authors:  Jeffrey B Kaplan; Chandran Ragunath; Narayanan Ramasubbu; Daniel H Fine
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

2.  Single protein production in living cells facilitated by an mRNA interferase.

Authors:  Motoo Suzuki; Junjie Zhang; Mohan Liu; Nancy A Woychik; Masayori Inouye
Journal:  Mol Cell       Date:  2005-04-15       Impact factor: 17.970

3.  Metabolic approaches for the optimisation of recombinant fermentation processes.

Authors:  M Cserjan-Puschmann; W Kramer; E Duerrschmid; G Striedner; K Bayer
Journal:  Appl Microbiol Biotechnol       Date:  1999-12       Impact factor: 4.813

4.  Bacterial bioreactors for high yield production of recombinant protein.

Authors:  Motoo Suzuki; Rohini Roy; Haiyan Zheng; Nancy Woychik; Masayori Inouye
Journal:  J Biol Chem       Date:  2006-10-04       Impact factor: 5.157

5.  Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli.

Authors:  Debra W Jackson; Kazushi Suzuki; Lawrence Oakford; Jerry W Simecka; Mark E Hart; Tony Romeo
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

6.  Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality.

Authors:  B Sat; R Hazan; T Fisher; H Khaner; G Glaser; H Engelberg-Kulka
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

7.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

8.  Improvement in recombinant protein production in ppGpp-deficient Escherichia coli.

Authors:  N Dedhia; R Richins; A Mesina; W Chen
Journal:  Biotechnol Bioeng       Date:  1997-02-20       Impact factor: 4.530

9.  MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli.

Authors:  Yonglong Zhang; Junjie Zhang; Klaus P Hoeflich; Mitsuhiko Ikura; Guoliang Qing; Masayori Inouye
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

10.  Metabolic engineering of Escherichia coli to enhance phenylalanine production.

Authors:  N Yakandawala; T Romeo; A D Friesen; S Madhyastha
Journal:  Appl Microbiol Biotechnol       Date:  2007-12-15       Impact factor: 4.813

View more
  4 in total

1.  Quantifying heterologous gene expression during ectopic MazF production in Escherichia coli.

Authors:  Nela Nikolic; Martina Sauert; Tanino G Albanese; Isabella Moll
Journal:  BMC Res Notes       Date:  2022-05-13

2.  Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.

Authors:  Jeffrey B Kaplan; Karen LoVetri; Silvia T Cardona; Srinivasa Madhyastha; Irina Sadovskaya; Saïd Jabbouri; Era A Izano
Journal:  J Antibiot (Tokyo)       Date:  2011-12-14       Impact factor: 2.649

3.  Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilms.

Authors:  Anke Gökçen; Andreas Vilcinskas; Jochen Wiesner
Journal:  Virulence       Date:  2013-01-28       Impact factor: 5.882

4.  Antibiofilm Efficacy of DispersinB(®) Wound Spray Used in Combination with a Silver Wound Dressing.

Authors:  Purushottam V Gawande; Allie P Clinton; Karen LoVetri; Nandadeva Yakandawala; Kendra P Rumbaugh; Srinivasa Madhyastha
Journal:  Microbiol Insights       Date:  2014-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.